Cargando…

Simulation of an HDR “Boost” with Stereotactic Proton versus Photon Therapy in Prostate Cancer: A Dosimetric Feasibility Study

PURPOSE/OBJECTIVES: To compare the dose escalation potential of stereotactic body proton therapy (SBPT) versus stereotactic body photon therapy (SBXT) using high-dose rate prostate brachytherapy (HDR-B) dose-prescription metrics. PATIENTS AND METHODS: Twenty-five patients previously treated with rad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Remick, Jill S., Sabouri, Pouya, Zhu, Mingyao, Bentzen, Søren M., Sun, Kai, Kwok, Young, Kaiser, Adeel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Particle Therapy Co-operative Group 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886266/ https://www.ncbi.nlm.nih.gov/pubmed/33604412 http://dx.doi.org/10.14338/IJPT-20-00029.1

Ejemplares similares

Feasibility of Proton Transmission-Beam Stereotactic Ablative Radiotherapy versus Photon Stereotactic Ablative Radiotherapy for Lung Tumors: A Dosimetric and Feasibility Study
por: Mou, Benjamin, et al.
Publicado: (2014)

Multiple Computed Tomography Robust Optimization to Account for Random Anatomic Density Variations During Intensity Modulated Proton Therapy
por: Zhu, Mingyao, et al.
Publicado: (2019)

Dosimetric comparison of surface mould HDR brachytherapy with VMAT
por: Boman, Eeva L., et al.
Publicado: (2018)

Dosimetric analysis and comparison of IMRT and HDR brachytherapy in treatment of localized prostate cancer
por: Murali, V., et al.
Publicado: (2010)

Dosimetric Comparison of Upfront Boosting With Stereotactic Radiosurgery Versus Intraoperative Radiotherapy for Glioblastoma
por: Sarria, Gustavo R., et al.
Publicado: (2021)

Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial
por: Belliveau, C., et al.
Publicado: (2022)

Brachytherapy Versus Stereotactic Body Radiotherapy for Cervical Cancer Boost: A Dosimetric Comparison
por: Dahbi, Zineb, et al.
Publicado: (2023)

Dosimetric comparison of inverse optimization with geometric optimization in combination with graphical optimization for HDR prostate implants
por: Jamema, Swamidas V., et al.
Publicado: (2006)

Evaluation of dosimetric functions for a new (169)Yb HDR Brachytherapy Source
por: Safaeipour, Elham, et al.
Publicado: (2021)

Dosimetric feasibility of stereotactic ablative radiotherapy in pulmonary vein isolation for atrial fibrillation using intensity‐modulated proton therapy
por: Ren, Xue‐Ying, et al.
Publicado: (2021)

Investigate the Dosimetric and Potential Clinical Benefits Utilizing Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost Technique for Locally Advanced Pancreatic Cancer: A Comparison Between Photon and Proton Beam Therapy
por: Liu, Peilin, et al.
Publicado: (2021)

Angiosarcoma of the Scalp and Face: A Dosimetric Comparison of HDR Surface Applicator Brachytherapy and VMAT
por: Mitra, Devarati, et al.
Publicado: (2020)

A biological modelling based comparison of radiotherapy plan robustness using photons vs protons for focal prostate boosting
por: Pedersen, Jesper, et al.
Publicado: (2018)

Dosimetric verification of source strength for HDR afterloading units with Ir-192 and Co-60 photon sources: Comparison of three different international protocols
por: Azhari, Hasin A., et al.
Publicado: (2012)

Erratum: Investigate the Dosimetric and Potential Clinical Benefits Utilizing Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost Technique for Locally Advanced Pancreatic Cancer: A Comparison Between Photon and Proton Beam Therapy
Publicado: (2022)

Simultaneous integrated boost with stereotactic radiotherapy for dominant intraprostatic lesion of localized prostate cancer: a dosimetric planning study
por: Kim, Yeon Joo, et al.
Publicado: (2020)

Stereotactic body proton therapy for liver tumors: Dosimetric advantages and their radiobiological and clinical implications
por: Arscott, W. Tristram, et al.
Publicado: (2018)

Dosimetric comparison of inverse optimisation methods versus forward optimisation in HDR brachytherapy of breast, cervical and prostate cancer
por: Fröhlich, Georgina, et al.
Publicado: (2019)

Cosmetic effect in patients with early breast cancer treated with breast conserving therapy (BCT) and with HDR brachytherapy (HDR-BT) “boost”
por: Kulik, Anna, et al.
Publicado: (2009)

Dosimetric Comparison of Proton Versus Photon Radiosurgery for Treatment of Pituitary Adenoma
por: Sud, Shivani, et al.
Publicado: (2021)

Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
por: Lee, Tae Hoon, et al.
Publicado: (2021)

Dosimetric characterization of Elekta stereotactic cones
por: Borzov, Egor, et al.
Publicado: (2017)

Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma
por: Abe, Takanori, et al.
Publicado: (2015)

Virtual HDR Boost for Prostate Cancer: Rebooting a Classic Treatment Using Modern Tech
por: Wegener, Eric, et al.
Publicado: (2023)

EGSnrc Monte Carlo-aided dosimetric studies of the new BEBIG (60)Co HDR brachytherapy source
por: Anwarul, Islam Mohammad, et al.
Publicado: (2013)

Design and Development of In-House Multichannel Applicator for HDR Vaginal Brachytherapy and Dosimetric Comparision with Single Channel Applicator
por: Govindaraj, Kesavan, et al.
Publicado: (2019)

Dosimetric evaluation of photons versus protons in postmastectomy planning for ultrahypofractionated breast radiotherapy
por: Oonsiri, Puntiwa, et al.
Publicado: (2022)

A pilot study of stereotactic boost for malignant epidural spinal cord compression: clinical significance and initial dosimetric evaluation
por: Donovan, Elysia K., et al.
Publicado: (2020)

Stereotactic Body Radiotherapy Boost with the CyberKnife for Locally Advanced Cervical Cancer: Dosimetric Analysis and Potential Clinical Benefits
por: Gao, Jiaxiang, et al.
Publicado: (2022)

Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors
por: Lischalk, Jonathan W., et al.
Publicado: (2018)

Dosimetric Uncertainties in Dominant Intraprostatic Lesion Simultaneous Boost Using Intensity Modulated Proton Therapy
por: Zhou, Jun, et al.
Publicado: (2021)

Reirradiation for Rectal Cancer Using Pencil Beam Scanning Proton Therapy: A Single Institutional Experience
por: Koroulakis, Antony, et al.
Publicado: (2020)

Dosimetric comparison between the microSelectron HDR (192)Ir v2 source and the BEBIG (60)Co source for HDR brachytherapy using the EGSnrc Monte Carlo transport code
por: Islam, M. Anwarul, et al.
Publicado: (2012)

Breast Conserving Treatment for Breast Cancer: Dosimetric Comparison of Sequential versus Simultaneous Integrated Photon Boost
por: Van Parijs, Hilde, et al.
Publicado: (2014)

A detailed dosimetric comparison between manual and inverse plans in HDR intracavitary/interstitial cervical cancer brachytherapy
por: Trnková, Petra, et al.
Publicado: (2011)

Dosimetric assessment of an air‐filled balloon applicator in HDR vaginal cuff brachytherapy using the Monte Carlo method
por: Jiang, Hongyu, et al.
Publicado: (2018)

A User-Friendly System for Mailed Dosimetric Audits of (192)Ir or (60)Co HDR Brachytherapy Sources
por: Oliver-Cañamás, Laura, et al.
Publicado: (2023)

MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer
por: Kazi, Aleksandra, et al.
Publicado: (2010)

External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy Boost
por: Panettieri, Vanessa, et al.
Publicado: (2020)

Feasibility and dosimetric evaluation of single- and multi-isocentre stereotactic body radiation therapy for multiple liver metastases
por: Tang, Chunbo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hlln63ntq10kqtdbmr0aile5ks